- Home
- NDMO vs AVNS Comparison
NDMO vs AVNS Comparison
Compare NDMO & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NDMO | AVNS |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 622.4M | 521.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NDMO | AVNS |
|---|---|---|
| Price | $10.32 | $11.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 218.6K | ★ 523.4K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 6.75% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $8.99 | $9.30 |
| 52 Week High | $11.24 | $19.18 |
Technical Indicators
Market Signals| Indicator | NDMO | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 38.43 | 45.17 |
| Support Level | $10.47 | $10.84 |
| Resistance Level | $10.66 | $12.34 |
| Average True Range (ATR) | 0.18 | 0.45 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 19.95 | 23.67 |
Price Performance
Historical ComparisonAbout NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest
Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.